Proximagen makes cash offer for Minster Pharmaceuticals

Wednesday 6 January 2010

Proximagen Neuroscience Plc, a university spin-out that raised £50 million in an offer of its shares in 2009, is making an agreed, all-cash offer for Minster Pharmaceuticals Plc. Both companies are developing CNS drug candidates. 

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom